Researchers at the Jacobs School of Medicine and Biomedical Sciences at the University at Buffalo have developed a new ...
Antibiotic treatments are losing effectiveness against a range of common bacterial pathogens, including E. coli, K.
Researchers at the Jacobs School of Medicine and Biomedical Sciences have developed a new inhalable form of tuberculosis (TB) treatment that could significantly reduce the burden of current therapy.
News Medical on MSN
Early tuberculosis treatment reduces sepsis deaths in HIV patients
Sepsis is a leading global cause of hospital deaths, occurring when the body's response to infection damages tissue and ...
A study comparing one- and three-month antibiotic treatments to prevent active tuberculosis (TB) finds that a high percentage ...
A new study in "Nature Medicine" estimates 2 million people are incorrectly told they have TB each year — and clinicians miss ...
A scourge for at least the past 6,000 years, tuberculosis (TB) is estimated by the World Health Organization (WHO) to be a ...
A study comparing one- and three-month antibiotic treatments to prevent active tuberculosis (TB) finds that a high percentage ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results